Aurora Cannabis Revenue 2017-2020 | ACB

Aurora Cannabis revenue from 2017 to 2020. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Aurora Cannabis Annual Revenue
(Millions of US $)
2019 $187
2018 $43
2017 $14
2016 $1
Aurora Cannabis Quarterly Revenue
(Millions of US $)
2020-03-31 $56
2019-12-31 $42
2019-09-30 $57
2019-06-30 $75
2019-03-31 $49
2018-12-31 $41
2018-09-30 $23
2018-06-30 $15
2018-03-31 $13
2017-12-31 $9
2017-09-30 $7
2017-06-30 $4
2017-03-31 $4
2016-12-31 $3
2016-09-30 $2
2016-06-30 $1
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $1.236B $0.215B
Aurora Cannabis Inc is a Canada-based company engaged in the production and distribution of medical cannabis. The Company is vertically integrated and horizontally diversified across every key segment of the value chain, from facility engineering and design to cannabis breeding and genetics research, cannabis and hemp production, derivatives, home cultivation, wholesale and retail distribution. The Company's purpose-built facilities, which integrate technologies across all processes, are defined by automation and customization. The Company has a funded capacity of more than 500,000 kilograms per year, as well as sales and operations in 24 countries across 5 continents.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $180.670B 33.93
Medtronic (MDT) Ireland $130.133B 21.14
Stryker (SYK) United States $70.453B 27.32
Boston Scientific (BSX) United States $52.797B 31.18
Lonza Group Ag (LZAGY) Switzerland $46.625B 0.00
Baxter (BAX) United States $40.731B 24.91
Terumo (TRUMY) Japan $29.507B 37.72
ResMed (RMD) United States $29.362B 42.64
EssilorLuxottica Societe Anonyme (ESLOY) France $28.435B 0.00
Zimmer Biomet Holdings (ZBH) United States $27.582B 22.96
Sunny Optical Technology (SNPTF) China $20.566B 0.00
Smith & Nephew SNATS (SNN) United Kingdom $17.909B 0.00
Bio-Rad Laboratories (BIO) United States $15.633B 70.78
Insulet (PODD) United States $13.583B 1345.75
Quidel (QDEL) United States $12.667B 67.10
Shandong Weigao Medical Polymer (SHWGF) China $11.849B 0.00
DiaSorin S.p.A (DSRLF) Italy $11.312B 0.00
GN STORE NORD (GNNDY) Denmark $8.157B 41.58
William Demant Holdings (WILYY) Denmark $7.457B 0.00
Canopy Growth (CGC) Canada $7.124B 0.00
Perrigo (PRGO) Ireland $7.086B 12.17
Hill-Rom Holdings (HRC) United States $6.344B 15.74
Neogen (NEOG) United States $4.261B 71.19
Hutchison China MediTech (HCM) Hong Kong, SAR China $4.215B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $4.189B 0.00
Haemonetics (HAE) United States $3.859B 25.71
ICU Medical (ICUI) United States $3.850B 28.08
Envista Holdings (NVST) United States $3.668B 25.01
Abcam (ABCZY) $3.384B 0.00
Agios Pharmaceuticals (AGIO) United States $2.992B 0.00
National Vision Holdings (EYE) United States $2.723B 47.11
NuVasive (NUVA) United States $2.623B 36.55
TG Therapeutics (TGTX) United States $2.288B 0.00
AtriCure (ATRC) United States $1.912B 0.00
DFB Healthcare Acquisitions (AHCO) United States $1.878B 172.92
MacroGenics (MGNX) United States $1.468B 0.00
NanoString Technologies (NSTG) United States $1.409B 0.00
Aphria (APHA) Canada $1.385B 0.00
OraSure Technologies (OSUR) United States $1.215B 0.00
Cerus (CERS) United States $1.194B 0.00
Meridian Bioscience (VIVO) United States $1.131B 42.60
Cardiovascular Systems (CSII) United States $1.084B 0.00
PetIQ (PETQ) United States $1.052B 30.39
InMode (INMD) Israel $1.034B 26.07
Quanterix (QTRX) United States $0.992B 0.00
Phibro Animal Health (PAHC) United States $0.965B 19.24
Owens & Minor (OMI) United States $0.898B 20.36
Vapotherm (VAPO) United States $0.837B 0.00
Omeros (OMER) United States $0.753B 0.00
BioLife Solutions (BLFS) United States $0.669B 190.46
Eagle Pharmaceuticals (EGRX) United States $0.668B 47.88
Surmodics (SRDX) United States $0.660B 72.36
VAREX IMAGING (VREX) United States $0.649B 16.13
Zynex (ZYXI) United States $0.629B 54.91
LeMaitre Vascular (LMAT) United States $0.591B 36.17
Lantheus Holdings (LNTH) United States $0.501B 11.67
Cytosorbents (CTSO) United States $0.417B 0.00
Viemed Healthcare (VMD) United States $0.409B 14.61
HEXO (HEXO) $0.326B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.325B 0.00
Utah Medical Products (UTMD) United States $0.294B 25.24
InfuSystems Holdings (INFU) United States $0.254B 140.56
Organigram Holdings (OGI) Canada $0.230B 0.00
Female Health (VERU) United States $0.217B 0.00
Chimerix (CMRX) United States $0.211B 0.00
Exagen (XGN) United States $0.176B 0.00
Bovie Medical (APYX) United States $0.171B 0.00
Surface Oncology (SURF) United States $0.169B 0.00
Fonar (FONR) United States $0.161B 14.29
Wound Management Technologies (SMTI) United States $0.161B 0.00
Liberty Health Sciences (LHSIF) Canada $0.128B 0.00
Rockwell Medical (RMTI) United States $0.124B 0.00
Chembio Diagnostics (CEMI) United States $0.120B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.119B 0.00
Capricor Therapeutics (CAPR) United States $0.117B 0.00
Evolus (EOLS) United States $0.112B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.093B 0.00
MTech Acquisition (KERN) United States $0.088B 0.00
Nephros (NEPH) United States $0.074B 0.00
United-Guardian (UG) United States $0.070B 16.33
Brainsway (BWAY) Israel $0.066B 0.00
Trinity Biotech (TRIB) Ireland $0.062B 0.00
ImmuCell (ICCC) United States $0.041B 0.00
GUARDION HEALTH (GHSI) United States $0.035B 0.00
Akers Biosciences Inc (AKER) United States $0.032B 0.00
FSD PHARMA INC (HUGE) Canada $0.027B 0.00
NF Energy Saving (BIMI) China $0.024B 0.00
Myomo (MYO) United States $0.011B 0.00
Conatus Pharmaceuticals (HSTO) United States $0.009B 0.00
Senestech (SNES) United States $0.007B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00